Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
CLEO Diagnostics Ltd ( (AU:COV) ) has provided an update.
CLEO Diagnostics Ltd has announced a proposed issuance of securities, including both unlisted options and fully paid ordinary shares, totaling over 9 million securities. This move is positioned to support the company’s financial strategy and may enhance its market position by providing additional funding for future growth initiatives.
The most recent analyst rating on (AU:COV) stock is a Buy with a A$1.15 price target. To see the full list of analyst forecasts on CLEO Diagnostics Ltd stock, see the AU:COV Stock Forecast page.
More about CLEO Diagnostics Ltd
CLEO Diagnostics Ltd operates in the diagnostics industry, focusing on the development and distribution of diagnostic solutions. It aims to provide innovative products addressing key healthcare challenges and catering to a growing market demand for advanced diagnostic tools.
Average Trading Volume: 235,995
Technical Sentiment Signal: Buy
Current Market Cap: A$88.02M
See more insights into COV stock on TipRanks’ Stock Analysis page.